Proapoptotic activity of NAG-1 is cell type specific and not related to COX-2 expression
Authors:
- 9 May 2006
- journal article
- Published by Springer Nature in Apoptosis
- Vol. 11 (7) , 1131-1138
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) activated gene (NAG-1) is a newly identified member of the transforming growth factor-β (TGF-β) superfamily. Members of the TGF-β family are multifunctional growth factors, and the nature of their effects depends on the cellular context and cell type. NAG-1 has antitumorigenic and proapoptotic activities in colon and gastric cancer cells lacking endogenous cyclooxgenase-2 (COX-2) expression. In contrast, COX-2 overexpression is related to antiapoptotic activity. The purpose of this study is to evaluate the proapoptotic activity of NAG-1 according to COX-2 expression and cell type. NAG-1 cDNA was transfected in SNU668 cells with endogenous COX-2 expression, SNU601 cells with forced COX-2 expression and Hep3B hepatocellular carcinoma cells. SNU668 cells with ectopic expression of NAG-1 showed markedly elevated subG1 population, induced death receptor-4 (DR-4) and DR-5, and revealed smaller active fragments of caspase-3. Forced COX-2 expression in SNU601 cells did not inhibit apoptosis caused by NAG-1 expression. Sulindac sulfide caused apoptosis, and induced expression of DR-5 and NAG-1 in Hep3B cells. However, Hep3B cells ectopically expressing NAG-1 did not cause apoptosis, and smaller active fragments of caspase-3 and an 85 kDa band of poly ADP-ribose polymerase (PARP) did not appear in the transfected cells, either. This study suggests that proapoptotic activity of NAG-1 is cell type specific and not related to COX-2 expression.Keywords
This publication has 20 references indexed in Scilit:
- Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosisCarcinogenesis, 2004
- Cyclooxygenase Inhibitors Regulate the Expression of a TGF-β Superfamily Member That Has Proapoptotic and Antitumorigenic ActivitiesMolecular Pharmacology, 2001
- Malignant Transformation and Antineoplastic Actions of Nonsteroidal Antiinflammatory Drugs (Nsaids) on Cyclooxygenase-Null Embryo FibroblastsJournal of Experimental Medicine, 1999
- Smads and early developmental signaling by the TGFβ superfamilyGenes & Development, 1998
- Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein FamilyJournal of Biological Chemistry, 1998
- Identification of a novel member of the TGF-beta superfamily highly expressed in human placentaGene, 1997
- MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamilyProceedings of the National Academy of Sciences of the United States of America, 1997
- PLAB, a novel placental bone morphogenetic proteinBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1997
- Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathwayBiochemical Pharmacology, 1996
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995